Dr Lal Pathlabs

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE600L01024
  • NSEID: LALPATHLAB
  • BSEID: 539524
INR
2,006.55
44.4 (2.26%)
BSENSE

Nov 20

BSE+NSE Vol: 2.75 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1000163,
    "name": "Dr Lal Pathlabs",
    "stock_name": "Dr Lal Pathlabs",
    "full_name": "Dr Lal Pathlabs Ltd",
    "name_url": "stocks-analysis/dr-lal-pathlabs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,006.55",
    "chg": 44.4,
    "chgp": "2.26%",
    "dir": 1,
    "prev_price": "1,962.15",
    "mcapval": "33,316.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 539524,
    "symbol": "LALPATHLAB",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE600L01024",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "2.75 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/dr-lal-pathlabs-1000163-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Dr Lal Pathlabs Gains 0.74%: Mixed Technical Signals and Valuation Concerns Shape the Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/dr-lal-pathlabs-gains-074-mixed-technical-signals-and-valuation-concerns-shape-the-week-4270428",
        "imagepath": "",
        "date": "2026-11-21 14:01:48",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Stock opens at Rs.2,004.90, up 0.66%</p>\n                    <p><strong>17 Nov:</strong> Downgrade to Hold by MarketsMOJO announced</p>\n                    <p><strong>18 Nov:</strong> Technical momentum shifts to mildly bullish; stock dips 1.26%</p>\n                    <p><strong>20 Nov:</strong> Stock rebounds 2.26% to close at Rs.2,006.55</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,991.75</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.2,006.55</div><div cl..."
      },
      {
        "title": "Dr Lal Pathlabs Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/dr-lal-pathlabs-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4266378",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/DrLalPathlabsLt_mojoScore_4266378.png",
        "date": "2026-11-18 08:31:21",
        "description": "Dr Lal Pathlabs Ltd, a prominent player in the healthcare services sector, has seen its investment rating downgraded from Buy to Hold as of 17 Nov 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technical indicators. While the company continues to demonstrate strong financial metrics and market-beating returns, evolving technical signals and stretched valuations have tempered investor enthusiasm."
      },
      {
        "title": "Dr Lal Pathlabs Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/dr-lal-pathlabs-ltd-technical-momentum-shifts-amid-mixed-market-signals-4266045",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/DrLalPathlabsLt_technicaldot_4266045.png",
        "date": "2026-11-18 08:04:42",
        "description": "Dr Lal Pathlabs Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of mid-November 2026. Despite a modest decline in the stock price on 18 Nov 2026, the underlying technical indicators present a complex picture, reflecting both cautious optimism and emerging bearish signals within the healthcare services sector."
      },
      {
        "title": "Dr Lal Pathlabs Ltd is Rated Buy by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/dr-lal-pathlabs-ltd-is-rated-buy-by-marketsmojo-4262359",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/DrLalPathlabsLt_mojoScore_4262359.png",
        "date": "2026-11-15 10:10:41",
        "description": "Dr Lal Pathlabs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 3 November 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 15 November 2026, providing investors with the most up-to-date view of the company’s fundamentals and market performance."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 2061.5",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/dr-lal-pathlabs-ltd-hits-new-52-week-high-at-rs-20615-4256721",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/DrLalPathlabsLt_priceRelatedfactors_4256721.png",
        "date": "2026-11-09 10:12:26",
        "description": "Surging to an intraday peak of Rs 2061.5 on 09 Nov 2026, Dr Lal Pathlabs Ltd has marked a fresh 52-week high, propelled by a confluence of robust technical indicators and sustained price momentum. This milestone caps a notable rally that has delivered 32.91% returns over the past year, comfortably outpacing the Sensex’s decline of 2.87% during the same period."
      },
      {
        "title": "Dr Lal Pathlabs Gains 3.14%: 5 Key Factors Driving the Week’s Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/dr-lal-pathlabs-gains-314-5-key-factors-driving-the-weeks-momentum-4255296",
        "imagepath": "",
        "date": "2026-11-07 14:02:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 2:</strong> Stock opens at Rs.1,887.50, down 0.99% amid broader Sensex gains</p>\n                    <p><strong>Nov 3:</strong> Mojo Grade upgraded to Buy by MarketsMOJO on strong metrics</p>\n                    <p><strong>Nov 4:</strong> New 52-week high touched intraday at Rs.2,013.60, closing near record levels</p>\n                    <p><strong>Nov 5:</strong> New 52-week high of Rs.2,050 reached, despite intraday pullback</p>\n                    <p><strong>Nov 6:</strong> Week closes at Rs.1,966.25, marginally down from previous day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div ..."
      },
      {
        "title": "Dr Lal Pathlabs Ltd Reports Flat Quarterly Performance Amid Mixed Financial Indicators",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/dr-lal-pathlabs-ltd-reports-flat-quarterly-performance-amid-mixed-financial-indicators-4252549",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/DrLalPathlabsLt_fintrenddot_4252549.png",
        "date": "2026-11-05 13:12:56",
        "description": "Dr Lal Pathlabs Ltd, a prominent player in the healthcare services sector, has reported a flat financial performance for the quarter ended September 2026 despite recording its highest-ever quarterly net sales and profit after tax. The company’s recent financial trend has shifted from positive to flat, reflecting a mixed bag of operational strengths and emerging challenges that investors should carefully consider."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 2050",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/dr-lal-pathlabs-ltd-hits-new-52-week-high-of-rs2050-4252242",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/DrLalPathlabsLt_priceRelatedfactors_4252242.png",
        "date": "2026-11-05 10:14:08",
        "description": "With a decisive break above Rs 2050 on 5 Nov 2026, Dr Lal Pathlabs Ltd has reached a fresh 52-week high, extending its impressive 27.19% return over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the Sensex is also trading near recent peaks."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 2013.6",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/dr-lal-pathlabs-ltd-hits-new-52-week-high-marking-significant-market-milestone-4250975",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/DrLalPathlabsLt_priceRelatedfactors_4250975.png",
        "date": "2026-11-04 15:13:20",
        "description": "With a decisive surge to an intraday peak of Rs 2013.6 on 4 Nov 2026, Dr Lal Pathlabs Ltd has nearly touched its 52-week high, closing just 1.06% shy of the Rs 2035 mark. This rally reflects a strong alignment of technical indicators and sustained price momentum, underscoring the stock’s robust upward trajectory amid a broadly positive market backdrop."
      }
    ],
    "total": 63,
    "sid": "1000163",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/dr-lal-pathlabs-1000163"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Nov-2026",
      "details": "Newspaper Publication",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "12-Nov-2026",
      "details": "Attached",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "11-Nov-2026",
      "details": "Attached",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dr Lal Pathlabs Ltd has declared <strong>50%</strong> dividend, ex-date: 11 Nov 26",
          "dt": "2026-11-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

13-Nov-2026 | Source : BSE

Newspaper Publication

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

12-Nov-2026 | Source : BSE

Attached

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

11-Nov-2026 | Source : BSE

Attached

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Dr Lal Pathlabs Ltd has declared 50% dividend, ex-date: 11 Nov 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available